Showing results (351-360 of 470) with videos related to
Sort By:
Pageof 47
Journal of the National Cancer Institute|June 1, 2021
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal CancerJun Yin, Romain Cohen, Zhaohui Jin, et al.The Lancet. Oncology|July 3, 2019
Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 studyTanios S Bekaii-Saab, Fang-Shu Ou, Daniel H Ahn, et al.The Oncologist|February 19, 2021
Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS TrialAminah Jatoi, Fang-Shu Ou, Daniel H Ahn, et al.Journal of the National Cancer Institute|August 25, 2020
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT DatabaseAnna D Wagner, Axel Grothey, Thierry Andre, et al.The Lancet. Oncology|January 21, 2023
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort studyJingyuan Wang, Joanne Xiu, Alex Farrell, et al.Clinical Colorectal Cancer|February 12, 2014
Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147Jocelin Huang, Suresh G Nair, Michelle R Mahoney, et al.Oncogene|July 11, 2026
Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subsetJingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2019
TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast CancerMothaffar F Rimawi, Polly Niravath, Tao Wang, et al.Cancer|October 16, 2012
Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trialMatthew R Callstrom, Damian E Dupuy, Stephen B Solomon, et al.Nature Communications|January 10, 2017
CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1Tongzheng Liu, Jia Yu, Min Deng, et al.Pageof 47